Interview Highlights: Dr. Tyson Welzel, Group Chief Innovation Officer, Mediclinic

Dr. Tyson Welzel, the Group Chief Innovation Officer at Mediclinic, and speaker at HBI 2024 in the session The race to net zero: decarbonising your operations, discussed the company’s commitment to carbon neutrality and innovation in healthcare. Mediclinic, a multinational healthcare provider, operates in Southern Africa, the Middle East, and Switzerland, with a significant share in the UK’s Spire Healthcare Group. Founded 40 years ago in South Africa, Mediclinic has evolved from an acute inpatient care provider to an integrated healthcare services provider, adapting to changing healthcare landscapes and technological advancements.

To drive innovation, Mediclinic established an Innovation Hub focused on supporting both incremental and radical changes in care provision. A critical part of their innovation strategy is achieving carbon neutrality and zero waste to landfill. This includes a multi-year budget and plan to ensure these goals are met. Mediclinic is implementing solar power in Southern Africa due to unreliable national electricity, reducing anaesthetic gas use in Switzerland, and saving water and energy through advanced systems in South Africa.

Welzel emphasised that achieving carbon neutrality requires collaboration with medical device manufacturers and pharmaceutical companies. Some manufacturers have started initiatives like reclaiming precious metals and plastics from single-use devices. Welzel looks forward to discussing these and other challenges with experts at the upcoming HBI 2024 conference.

To read the full interview, visit Healthcare Business International’s website and dive deeper into Dr. Tyson Welzel’s insights on innovation and sustainability at Mediclinic.

Key Trends Driving the Medical Aesthetics Market: Insight from L.E.K. Consulting

In this interview, Adrienne Rivlin of L.E.K. Consulting explores key trends in medical aesthetics, highlighting consumer interest, innovation, medical spas,…

The Adoption of AI in Pathology: Interview with Tribun Health’s Jean-François Pomerol

In this interview, we discuss the advancements and future of digital pathology with Jean-François Pomerol, CEO of Tribun Health. Learn…

Opportunities driven by change: Embracing a New Venue, Volume, and Value

As an event organiser, there is always a growing sense of anticipation that builds to a crescendo before the start…